WHO ICTRP trial

Clinical Study on the Impact of Droperidol on the Postoperative Sleep Quality of…

ChiCTR2500097665 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500097665
Public title Clinical Study on the Impact of Droperidol on the Postoperative Sleep Quality of Breast Cancer Patients
Scientific title Clinical Study on the Impact of Droperidol on the Postoperative Sleep Quality of Breast Cancer Patients
Primary sponsor The First Affiliated Hospital of Chongqing Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions breast cancer
Interventions Experimental group:At the end of the operation, 0.1mg/kg haloperidol were given;Control group:At the end of the operation, 0.1mg/kg saline were given
Registration date Feb 24, 2025
Target size Experimental group:72;Control group:72
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations